Referred to the Subcommittee on Livestock, Dairy, and Poultry.
This bill would prohibit the use of animals in federally funded research, with phased-in timelines for certain research categories and defined exceptions.
It creates a Federal Research Modernization Fund at the NSF to support non-animal methods, requires federally funded facilities to establish animal release programs, mandates audits and reporting, and imposes penalties for violations.
The bill allows rare, one-year congressional authorizations for animal use in infectious disease or national security research, and directs public databases and oversight.
Transformative, high-impact restrictions on biomedical research face strong institutional, scientific, and fiscal pushback; modest transition measures unlikely to offset resistance.
How solid the drafting looks.
Animal welfare and alternative science versus biomedical research continuity
Animal welfare and alternative science versus biomedical research continuity
Generally supportive on animal welfare and investment in non-animal science, while noting concerns about execution.
Would welcome the modernization fund and rehoming requirements, but watch for adequate funding and protections for public-health research.
Some projected impacts on biomedical progress are speculative and contingent on implementation details.
Cautiously optimistic about promoting modern scientific methods and animal welfare, but concerned about practical effects on biomedical and drug testing.
Views phased-in timelines and GAO oversight positively, while seeking clarity on costs, timelines, and interactions with FDA requirements.
Many impacts are uncertain until agencies and GAO reports appear.
Likely opposed overall due to federal overreach, potential harm to biomedical research, and added regulatory burdens.
Views prohibition, override of existing laws, and civil penalties as threats to scientific autonomy, national security, and taxpayer interests.
Some administrative benefits like rehoming are acknowledged but secondary.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Transformative, high-impact restrictions on biomedical research face strong institutional, scientific, and fiscal pushback; modest transition measures unlikely to offset resistance.
The bill has not accumulated any surfaced votes yet.
Animal welfare and alternative science versus biomedical research continuity
Transformative, high-impact restrictions on biomedical research face strong institutional, scientific, and fiscal pushback; modest transiti…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for SPARE Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.